Nipocalimab Reduces IgG, Appears Safe for Myasthenia Gravis in Adolescents

(MedPage Today) -- Investigational nipocalimab reduced serum immunoglobulin G (IgG), improved functional scores, and was well tolerated in adolescents with generalized myasthenia gravis, according to data from an open-label study presented at the...